End of life in patients attended by pediatric palliative care teams: what factors influence the place of death and compliance with family preferences?

Advance directives Child mortality Decision-making Infant death palliative care Right to die Terminal care

Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
May 2023
Historique:
received: 13 10 2022
accepted: 08 02 2023
revised: 05 02 2023
medline: 15 5 2023
pubmed: 9 3 2023
entrez: 8 3 2023
Statut: ppublish

Résumé

Each year, more than 8 million children worldwide require specialized palliative care, yet there is little evidence available in pediatrics on the characteristics of the end of life in this context. Our aim is to analyze the characteristics of patients who die in the care of specific pediatric palliative care teams. This is ambispective, analytical observational, multicenter study conducted between 1 January and 31 December 2019. Fourteen specific pediatric palliative care teams participated. There are 164 patients, most of them suffering from oncologic, neurologic, and neuromuscular processes. The follow-up time was 2.4 months. The parents voiced preferences in respect of the place of death for 125 of the patients (76.2%). The place of death for 95 patients (57.9%) was at the hospital and 67 (40.9%) was at home. The existence of a palliative care team for over 5 years is more likely to be related to families voicing preferences and their fulfillment. Longer follow-up times by pediatric palliative care teams were observed in families with whom preferences regarding the place of death were discussed and in patients who died at home. Patients who did not receive home visits, when the pediatric palliative care team did not provide full care and when preferences regarding the place of death were not discussed with parents, were more likely to die in the hospital.   Conclusions: Advance planning of end-of-life care is one of the most important aspects of pediatric palliative care. The provision of services by the teams and the follow-up time are related to parents' expressed preferences and the place of death. What is Known: • Various studies have shown how the availability of pediatric palliative care services improves the quality of life of patients and their families while reducing costs. • The place of death is an important factor influencing the quality of end-of-life care for dying people. The increase in palliative care teams increases the number of deaths in the home and having this care available 24/7 increases the probability of dying at home. What is New: • Our study identifies how a longer follow-up time of patients by palliative care teams is significantly associated with death at home and with express and comply with the preferences expressed by families. • Home visits by the palliative care team increase the likelihood that the patient will die at her home and that the preferences expressed by the palliative care team families will be cared for.

Identifiants

pubmed: 36890334
doi: 10.1007/s00431-023-04870-z
pii: 10.1007/s00431-023-04870-z
pmc: PMC10175312
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2369-2377

Informations de copyright

© 2023. The Author(s).

Références

Palliat Med. 2021 Jan;35(1):219-230
pubmed: 33307990
Policy Brief UCLA Cent Health Policy Res. 2012 Aug;(PB2012-3):1-8
pubmed: 22946141
J Epidemiol Community Health. 2016 Jan;70(1):17-24
pubmed: 26202254
Arch Dis Child. 2017 May;102(5):468-471
pubmed: 27919885
Pediatr Blood Cancer. 2011 Sep;57(3):361-8
pubmed: 21416582
J Pain Symptom Manage. 2009 Jan;37(1):33-43
pubmed: 18538973
Pediatrics. 2014 Sep;134(3):e765-72
pubmed: 25157003
An Pediatr (Engl Ed). 2021 Jul 21;:
pubmed: 34303629
J Pediatr. 2015 Jan;166(1):4-5
pubmed: 25527850
Ann Intern Med. 2008 Jan 15;148(2):147-59
pubmed: 18195339
J Clin Oncol. 2007 Oct 1;25(28):4472-6
pubmed: 17906208
Oncotarget. 2018 Apr 3;9(25):17867-17875
pubmed: 29707152
Ital J Pediatr. 2019 Jul 22;45(1):89
pubmed: 31331362
Lancet. 2014 May 3;383(9928):1547-8
pubmed: 24792853
Paediatr Nurs. 2010 Apr;22(3):31-6
pubmed: 20426356
JAMA. 2016 Nov 22;316(20):2104-2114
pubmed: 27893131
Palliat Care Soc Pract. 2020 Sep 25;14:2632352420958000
pubmed: 33033802
Arch Dis Child. 1990 Jun;65(6):641-3
pubmed: 1696094
Pediatr Blood Cancer. 2010 Feb;54(2):279-83
pubmed: 19830826
Eur J Pediatr. 2021 Mar;180(3):949-957
pubmed: 33030601
BMC Palliat Care. 2018 Jan 03;17(1):11
pubmed: 29298714
Res Dev Disabil. 2014 Nov 8;36C:264-276
pubmed: 25462487
BMJ Support Palliat Care. 2021 Sep 13;:
pubmed: 34518283
Schmerz. 2008 Aug;22(4):401-8
pubmed: 18516628
Eur J Cancer. 2011 Sep;47(14):2175-81
pubmed: 21531128
BMJ Open. 2018 Aug 13;8(8):e018576
pubmed: 30104308
J Pain Symptom Manage. 2017 Jun;53(6):1079-1084.e1
pubmed: 28457746
J Pain Symptom Manage. 2022 May;63(5):e529-e543
pubmed: 35031506
BMC Pediatr. 2017 Dec 22;17(1):215
pubmed: 29273020
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
Rev Paul Pediatr. 2022 Jan 05;40:e2021002
pubmed: 35019011
J Pain Symptom Manage. 2017 Feb;53(2):171-177
pubmed: 27765706
Eur J Pediatr. 2020 Aug;179(8):1227-1238
pubmed: 32607620
BMC Pediatr. 2014 Aug 08;14:199
pubmed: 25102958
Pediatrics. 2013 Mar;131(3):e873-80
pubmed: 23400610
Prim Care. 2019 Sep;46(3):461-473
pubmed: 31375193
BMC Palliat Care. 2018 Feb 12;17(1):23
pubmed: 29433576
Eur J Pediatr. 2017 Mar;176(3):327-335
pubmed: 28070671
Pediatr Res. 2021 Apr;89(5):1065-1077
pubmed: 32645707
J Pediatr Nurs. 2020 Nov - Dec;55:126-133
pubmed: 32949852
J Pain Symptom Manage. 2017 Aug;54(2):159-166
pubmed: 28602938
J Palliat Med. 2013 Apr;16(4):342-8
pubmed: 23249403

Auteurs

Maria José Peláez-Cantero (MJ)

Department of Paediatric Palliative Medicine, Maternal-Child of Malaga, Regional University Hospital. University of Málaga, Málaga, Spain. 0617368561@alu.uma.es.

Jose Miguel Morales-Asencio (JM)

University of Málaga. Malaga Biomedical Research Institute (IBIMA), Málaga, Spain.

Álvaro Navarro-Mingorance (Á)

Department of Paediatric Palliative Medicine, Niño Jesus University Children's Hospital, Madrid, Spain.

Aurora Madrid-Rodriguez (A)

Department of Paediatric Palliative Medicine, Maternal-Child of Malaga, Regional University Hospital. University of Málaga, Málaga, Spain.

Ángela Tavera-Tolmo (Á)

Department of Paediatric Palliative Medicine, Son Espases University Hospital, Mallorca, Spain.

Olga Escobosa-Sánchez (O)

Department of Paediatric Palliative Medicine, Virgen de Las Nieves University Hospital, Granada, Spain.

Ricardo Martino-Alba (R)

Department of Paediatric Palliative Medicine, Niño Jesus University Children's Hospital, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH